# Dendritic Cell Vaccine for Head and Neck Cancer

> **NCT00492947** · PHASE1 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **BIOLOGICAL:** dendritic cell vaccine

## Key facts

- **NCT ID:** NCT00492947
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-06
- **Primary completion:** 2010-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** major amendments in progress
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492947, "Dendritic Cell Vaccine for Head and Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00492947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*